Abstract
Although evidence exists for a daily rhythm in bone metabolism, the contribution of factors such as melatonin levels, the light–dark cycle, and the sleep–wake cycle is difficult to differentiate given their highly correlated time courses. To examine these influences on bone resorption, we collected 48-h sequential urine samples under both ambulatory (8-h sleep:16-h wake) and constant routine (CR) (constant wake, posture, nutrition and dim light) conditions from 20 healthy premenopausal women. Urinary 6-sulphatoxymelatonin (aMT6s; ng/h) and the bone resorption marker amino-terminal cross-linked collagen I telopeptide (NTx; bone collagen equivalents nM/h) were assayed and fit by cosinor models to determine significant 24-h rhythms and acrophase. Most participants had significant 24-h aMT6s rhythms during both ambulatory and CR conditions (95 and 85%, respectively), but fewer had significant 24-h NTx rhythms (70 and 70%, respectively). Among individuals with significant rhythms, mean (± SD) aMT6s acrophase times were 3:57 ± 1:50 and 3:43 ± 1:25 h under ambulatory and CR conditions, respectively, and 23:44 ± 5:55 and 3:06 ± 5:15 h, respectively, for NTx. Mean 24-h levels of both aMT6s and NTx were significantly higher during CR compared with ambulatory conditions (p < 0.0001 and p = 0.03, respectively). Menstrual phase (follicular versus luteal) had no impact on aMT6s or NTx timing or 24-h levels. This study confirms an endogenous circadian rhythm in NTx with a night-time peak when measured under CR conditions, but also confirms that environmental factors such as the sleep–wake or light–dark cycles, posture or meal timing affects overall concentrations and peak timing under ambulatory conditions, the significance of which remains unclear.
Similar content being viewed by others
References
Nakade O, Koyama H, Ariji H, Yajima A, Kaku T (1999) Melatonin stimulates proliferation and type I collagen synthesis in human bone cells in vitro. J Pineal Res 27:106–110
Ladizesky MG, Cutrera RA, Boggio V, Somoza J, Centrella JM, Mautalen C, Cardinali DP (2001) Effect of melatonin on bone metabolism in ovariectomized rats. Life Sci 70:557–565
Cardinali DP, Ladizesky MG, Boggio V, Cutrera RA, Mautalen C (2003) Melatonin effects on bone: experimental facts and clinical perspectives. J Pineal Res 34:81–87
Satomura K, Tobiume S, Tokuyama R, Yamasaki Y, Kudoh K, Maeda E, Nagayama M (2007) Melatonin at pharmacological doses enhances human osteoblastic differentiation in vitro and promotes mouse cortical bone formation in vivo. J Pineal Res 42:231–239
Sanchez-Barcelo EJ, Mediavilla MD, Tan DX, Reiter RJ (2010) Scientific basis for the potential use of melatonin in bone diseases: osteoporosis and adolescent idiopathic scoliosis. J Osteoporos 2010:830231
Witt-Enderby PA, Slater JP, Johnson NA, Bondi CD, Dodda BR, Kotlarczyk MP, Clafshenkel WP, Sethi S, Higginbotham S, Rutkowski JL, Gallagher KM, Davis VL (2012) Effects on bone by the light/dark cycle and chronic treatment with melatonin and/or hormone replacement therapy in intact female mice. J Pineal Res 53:374–384
Radio NM, Doctor JS, Witt-Enderby PA (2006) Melatonin enhances alkaline phosphatase activity in differentiating human adult mesenchymal stem cells grown in osteogenic medium via MT2 melatonin receptors and the MEK/ERK (1/2) signaling cascade. J Pineal Res 40:332–342
Roth JA, Kim BG, Lin WL, Cho MI (1999) Melatonin promotes osteoblast differentiation and bone formation. J Biol Chem 274:22041–22047
Sethi S, Radio NM, Kotlarczyk MP, Chen CT, Wei YH, Jockers R, Witt-Enderby PA (2010) Determination of the minimal melatonin exposure required to induce osteoblast differentiation from human mesenchymal stem cells and these effects on downstream signaling pathways. J Pineal Res 49:222–238
Koyama H, Nakade O, Takada Y, Kaku T, Lau KH (2002) Melatonin at pharmacologic doses increases bone mass by suppressing resorption through down-regulation of the RANKL-mediated osteoclast formation and activation. J Bone Miner Res 17:1219–1229
Suzuki N, Hattori A (2002) Melatonin suppresses osteoclastic and osteoblastic activities in the scales of goldfish. J Pineal Res 33:253–258
Ostrowska Z, Kos-Kudla B, Marek B, Kajdaniuk D (2003) Influence of lighting conditions on daily rhythm of bone metabolism in rats and possible involvement of melatonin and other hormones in this process. Endocr Regul 37:163–174
Ostrowska Z, Kos-Kudla B, Nowak M, Swietochowska E, Marek B, Gorski J, Kajdaniuk D, Wolkowska K (2003) The relationship between bone metabolism, melatonin and other hormones in sham-operated and pinealectomized rats. Endocr Regul 37:211–224
Kotlarczyk MP, Lassila HC, O’Neil CK, D’Amico F, Enderby LT, Witt-Enderby PA, Balk JL (2012) Melatonin osteoporosis prevention study (MOPS): a randomized, double-blind, placebo-controlled study examining the effects of melatonin on bone health and quality of life in perimenopausal women. J Pineal Res 52:414–426
Amstrup AK, Sikjaer T, Heickendorff L, Mosekilde L, Rejnmark L (2015) Melatonin improves bone mineral density at the femoral neck in postmenopausal women with osteopenia: a randomized controlled trial. J Pineal Res 59:221–229
Joseph F, Chan BY, Durham BH, Ahmad AM, Vinjamuri S, Gallagher JA, Vora JP, Fraser WD (2007) The circadian rhythm of osteoprotegerin and its association with parathyroid hormone secretion. J Clin Endocrinol Metab 92:3230–3238
Eastell R, Calvo MS, Burritt MF, Offord KP, Russell RG, Riggs BL (1992) Abnormalities in circadian patterns of bone resorption and renal calcium conservation in type I osteoporosis. J Clin Endocrinol Metab 74:487–494
Berruti A, Dogliotti L, Gorzegno G, Torta M, Tampellini M, Tucci M, Cerutti S, Frezet MM, Stivanello M, Sacchetto G, Angeli A (1999) Differential patterns of bone turnover in relation to bone pain and disease extent in bone in cancer patients with skeletal metastases. Clin Chem 45:1240–1247
Fraser WD, Anderson M, Chesters C, Durham B, Ahmad A, Chattington P, Vora J, Squire C, Diver M (2001) Circadian rhythm studies of serum bone resorption markers: implications for optimal sample timing and clinical utility. In: Eastell R, Baumann M, Hoyle NR, Wieczorek L (eds) Bone markers: biochemical and clinical perspectives. Martin Dunitz, London, pp 107–118
Rejnmark L, Vestergaard P, Heickendorff L, Andreasen F, Mosekilde L (2001) Loop diuretics alter the diurnal rhythm of endogenous parathyroid hormone secretion. A randomized-controlled study on the effects of loop- and thiazide-diuretics on the diurnal rhythms of calcitropic hormones and biochemical bone markers in postmenopausal women. Eur J Clin Invest 31:764–772
Qvist P, Christgau S, Pedersen BJ, Schlemmer A, Christiansen C (2002) Circadian variation in the serum concentration of C-terminal telopeptide of type I collagen (serum CTx): effects of gender, age, menopausal status, posture, daylight, serum cortisol, and fasting. Bone 31:57–61
Hassager C, Risteli J, Risteli L, Jensen SB, Christiansen C (1992) Diurnal variation in serum markers of type I collagen synthesis and degradation in healthy premenopausal women. J Bone Miner Res 7:1307–1311
Heshmati HM, Riggs BL, Burritt MF, McAlister CA, Wollan PC, Khosla S (1998) Effects of the circadian variation in serum cortisol on markers of bone turnover and calcium homeostasis in normal postmenopausal women. J Clin Endocrinol Metab 83:751–756
Generali D, Berruti A, Tampellini M, Dovio A, Tedoldi S, Bonardi S, Tucci M, Allevi G, Aguggini S, Milani M, Bottini A, Dogliotti L, Angeli A (2007) The circadian rhythm of biochemical markers of bone resorption is normally synchronized in breast cancer patients with bone lytic metastases independently of tumor load. Bone 40:182–188
Pellegrini GG, Gonzales Chaves MM, Fajardo MA, Ponce GM, Toyos GI, Lifshitz F, Friedman SM, Zeni SN (2012) Salivary bone turnover markers in healthy pre- and postmenopausal women: daily and seasonal rhythm. Clin Oral Investig 16:651–657
Duffy JF, Dijk DJ (2002) Getting through to circadian oscillators: why use constant routines? J Biol Rhythms 17:4–13
Gooley JJ, Rajaratnam SMW, Brainard GC, Kronauer RE, Czeisler CA, Lockley SW (2010) Spectral responses of the human circadian system depend on the irradiance and duration of exposure to light. Sci Transl Med 2:31ra3
Aldhous ME, Arendt J (1988) Radioimmunoassay for 6-sulphatoxymelatonin in urine using an iodinated tracer. Ann Clin Biochem 25:298–303
Lockley SW, Skene DJ, Arendt J, Tabandeh H, Bird AC, Defrance R (1997) Relationship between melatonin rhythms and visual loss in the blind. J Clin Endocrinol Metab 82:3763–3770
Skene DJ, Lockley SW, James K, Arendt J (1999) Correlation between urinary cortisol and 6-sulphatoxymelatonin rhythms in field studies of blind subjects. Clin Endocrinol (Oxf) 50:715–719
Gunn PJ, Middleton B, Davies SK, Revell VL, Skene DJ (2016) Sex differences in the circadian profiles of melatonin and cortisol in plasma and urine matrices under constant routine conditions. Chronobiol Int 33:39–50
Ostrowska Z, Kos-Kudla B, Marek B, Swietochowska E, Gorski J (2001) Assessment of the relationship between circadian variations of salivary melatonin levels and type I collagen metabolism in postmenopausal obese women. Neuro Endocrinol Lett 22:121–127
Fuleihan E-H, Klerman EB, Brown E, Czeisler CA (1997) N-Tx diurnal rhythm is truly endogenous. ASBMR Annual Meeting
Buehlmeier J, Frings-Meuthen P, Mohorko N, Lau P, Mazzucco S, Ferretti JL, Biolo G, Pisot R, Simunic B, Rittweger J (2017) Markers of bone metabolism during 14 days of bed rest in young and older men. J Musculoskelet Neuronal Interact 17:399–408
Morgan JL, Zwart SR, Heer M, Ploutz-Snyder R, Ericson K, Smith SM (2012) Bone metabolism and nutritional status during 30-day head-down-tilt bed rest. J Appl Physiol 1985 113:1519–1529
LeBlanc A, Shackelford L, Schneider V (1998) Future human bone research in space. Bone 22:113S–116S
Chua EC, Shui G, Lee IT, Lau P, Tan LC, Yeo SC, Lam BD, Bulchand S, Summers SA, Puvanendran K, Rozen SG, Wenk MR, Gooley JJ (2013) Extensive diversity in circadian regulation of plasma lipids and evidence for different circadian metabolic phenotypes in humans. Proc Natl Acad Sci USA 110:14468–14473
Rahman SA, Castanon-Cervantes O, Scheer FA, Shea SA, Czeisler CA, Davidson AJ, Lockley SW (2015) Endogenous circadian regulation of pro-inflammatory cytokines and chemokines in the presence of bacterial lipopolysaccharide in humans. Brain Behav Immun 47:4–13
Greenspan SL, Dresner-Pollak R, Parker RA, London D, Ferguson L (1997) Diurnal variation of bone mineral turnover in elderly men and women. Calcif Tissue Int 60:419–423
Lucassen EA, Coomans CP, van Putten M, de Kreij SR, van Genugten JH, Sutorius RP, de Rooij KE, van der Velde M, Verhoeve SL, Smit JW, Löwik CW, Smits HH, Guigas B, Aartsma-Rus AM, Meijer JH (2016) Environmental 24-hr cycles are essential for health. Curr Biol 26:1843–1853
Quevedo I, Zuniga AM (2010) Low bone mineral density in rotating-shift workers. J Clin Densitom 13:467–469
Kim BK, Choi YJ, Chung YS (2013) Other than daytime working is associated with lower bone mineral density: the Korea National Health and Nutrition Examination Survey 2009. Calcif Tissue Int 93:495–501
Feskanich D, Hankinson SE, Schernhammer ES (2009) Nightshift work and fracture risk: the Nurses’ Health Study. Osteoporos Int 20:537–542
Dijk DJ, Neri DF, Wyatt JK, Ronda JM, Riel E, Ritz-De Cecco A, Hughes RJ, Elliott AR, Prisk GK, West JB, Czeisler CA (2001) Sleep, performance, circadian rhythms, and light-dark cycles during two space shuttle flights. Am J Physiol Regul Integr Comp Physiol 281:R1647–R1664
Barger LK, Flynn-Evans EE, Kubey A, Walsh L, Ronda JM, Wang W, Wright KP Jr, Czeisler CA (2014) Prevalence of sleep deficiency and use of hypnotic drugs in astronauts before, during, and after spaceflight: an observational study. Lancet Neurol 13:904–912
Sibonga JD, Spector ER, Johnston SL, Tarver WJ (2015) Evaluating bone loss in ISS astronauts. Aerosp Med Hum Perform 86:A38–A44
Cappellesso R, Nicole L, Guido A, Pizzol D (2015) Spaceflight osteoporosis: current state and future perspective. Endocr Regul 49:231–239
Duffy JF, Zitting KM, Chinoy ED (2015) Aging and circadian rhythms. Sleep Med Clin 10:423–434
Wang K, Wu Y, Yang Y, Chen J, Zhang D, Hu Y, Liu Z, Xu J, Shen Q, Zhang N, Mao X, Liu C (2015) The associations of bedtime, nocturnal, and daytime sleep duration with bone mineral density in pre- and post-menopausal women. Endocrine 49:538–548
Nishizawa Y, Ohta H, Miura M, Inaba M, Ichimura S, Shiraki M, Takada J, Chaki O, Hagino H, Fujiwara S, Fukunaga M, Miki T, Yoshimura N (2013) Guidelines for the use of bone metabolic markers in the diagnosis and treatment of osteoporosis (2012 edition). J Bone Miner Metab 31:1–15
Wright KP Jr, Gronfier C, Duffy JF, Czeisler CA (2005) Intrinsic period and light intensity determine the phase relationship between melatonin and sleep in humans. J Biol Rhythms 20:168–177
Sletten TL, Vincenzi S, Redman JR, Lockley SW, Rajaratnam SMW (2010) Timing in sleep and its relationship with the endogenous melatonin rhythm. Front Neurol 1:137
Gooley JJ, Chamberlain K, Smith KA, Khalsa SB, Rajaratnam SM, Van Reen E, Zeitzer JM, Czeisler CA, Lockley SW (2011) Exposure to room light before bedtime suppresses melatonin onset and shortens melatonin duration in humans. J Clin Endocrinol Metab 96:E463–E472
Singh R, Singh RK, Mahdi AA, Saxena SP, Cornélissen G, Halberg F (2000) Circadian periodicity of urinary volume, creatinine and 5-hydroxyindole acetic acid excretion in healthy indians. Life Sci 66:209–214
Wisser H, Breuer H (1981) Circadian changes of clinical chemical and endocrinological parameters. J Clin Chem Clin Biochem 19:323–337
Kanabrocki EL, Sothern RB, Sackett-Lundeen L, Ryan MD, Johnson M, Foley S, Dawson S, Ocasio T, McCormick JB, Haus E, Kaplan E, Nemchausky B (2008) Creatinine clearance and blood pressure: a 34-year circadian study. Clin Ter 159:409–417
Kamperis K, Hagstroem S, Radvanska E, Rittig S, Djurhuus JC (2010) Excess diuresis and natriuresis during acute sleep deprivation in healthy adults. Am J Physiol Renal Physiol 299:F404–F411
Arendt J (1995) Melatonin and the mammalian pineal gland. Chapman and Hall, London
Uebelhart D, Schlemmer A, Johansen JS, Gineyts E, Christiansen C, Delmas PD (1991) Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links. J Clin Endocrinol Metab 72:367–373
Schlemmer A, Hassager C, Jensen SB, Christiansen C (1992) Marked diurnal variation in urinary excretion of pyridinium cross-links in premenopausal women. J Clin Endocrinol Metab 74:476–480
de la Piedra C, Traba ML, Dominguez Cabrera C, Sosa Henriquez M (1997) New biochemical markers of bone resorption in the study of postmenopausal osteoporosis. Clin Chim Acta 265:225–234
Flynn-Evans EE, Tabandeh H, Skene DJ, Lockley SW (2014) Circadian rhythm disorders and melatonin production in 127 blind women with and without light perception. J Biol Rhythms 29:215–224
Acknowledgements
MAStH and SAR were supported by a National Heart, Lung and Blood Institute fellowship in the program of training in Sleep, Circadian and Respiratory Neurobiology at Brigham and Women’s Hospital (T32 HL079010). PWE was supported by the Resident Fellow Translational Research Program in the Division of Clinical, Social and Administrative Sciences at the Duquesne University School of Pharmacy.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
In the last 24 months, MAStH has provided consulting services to The MathWorks Inc., MentalWorkout, and the Cooperative Research Centre for Alertness, Safety and Productivity, Australia. None of these commercial interests are related to the research or topic reported in this article. SAR, JJG, and PWE report no conflicts of interest. SWL has had a number of commercial interests in the last 24 months. None of them are directly related to the research or topic reported in this article; however, in the interests of full disclosure, are outlined below. In the past 2 years (2014–2016), SWL has received consulting fees from the Atlanta Falcons, Atlanta Hawks, Carbon Limiting Technologies Ltd on behalf of PhotonStar LED, Perceptive Advisors, and Serrado Capital; has current consulting contracts with Akili Interactive, Delos Living LLC, Environmental Light Sciences LLC, Focal Point LLC, Headwaters Inc., Hintsa Performance AG, Light Cognitive, OpTerra Energy Services Inc., Pegasus Capital Advisors LP, PlanLED, and Wyle Integrated Science and Engineering; owns equity in iSleep pty, Australia; has received unrestricted equipment gifts from Bioilluminations LLC, Bionetics Corporation, and F. Lux Software LLC; has received royalties from Oxford University Press; has received honoraria plus travel, accommodation or meals for invited seminars, conference presentations or teaching from Estee Lauder, Informa Exhibitions (USGBC), and Lightfair; travel, accommodation and/or meals only (no honoraria) for invited seminars, conference presentations or teaching from FASEB, Lightfair and USGBC. Through Brigham and Women’s Hospital, SWL has ongoing investigator-initiated research Grants from Biological Illuminations LLC and F. Lux Software LLC; has completed service agreements with Rio Tinto Iron Ore and Vanda Pharmaceuticals Inc; and had completed three sponsor-initiated clinical research contracts with Vanda Pharmaceuticals Inc. SWL holds process patents for the use of short-wavelength light for resetting the human circadian pacemaker and improving alertness and performance, and for a novel method to measure sleep, which are assigned to the Brigham and Women’s Hospital per Hospital policy. SWL has also served as a paid expert in arbitrations related to sleep, circadian rhythms and work hours and legal proceedings related to light, sleep and health. SWL is also a Program Leader for the Cooperative Research Centre for Alertness, Safety and Productivity, Australia.
Electronic supplementary material
Below is the link to the electronic supplementary material.
About this article
Cite this article
St Hilaire, M.A., Rahman, S.A., Gooley, J.J. et al. Relationship between melatonin and bone resorption rhythms in premenopausal women. J Bone Miner Metab 37, 60–71 (2019). https://doi.org/10.1007/s00774-017-0896-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00774-017-0896-6